Replies to post #527 on BioAdaptives Inc (BDPT)

[RCL Cruiser]

I certainly don't know but it is a nice problem to have.

[John Gault]

I think what is driving BDPT is:
1) CEO has a proven track record. He was the CFO for US Tel which he took the purchase of a switch from Drexal into a 50 million dollar NASDAQ company.
2) Very small float
3) No insider selling that I can see from the filing. They obviously think this is a bigger play than 5 or 6 bucks
4)A stem cell technology with clinical trials
IMHO, That's why I'm holding for a year or two, not based on timing myself in and out over the next year.